Healthcare Global Enterprises Ltd IPO Message Board (Page 14)

YAD KARO VO KURBANI, JO HAMNE QUICKHEAL ME DI THI.
MANY MANY MONEY LOSS IN QUICKHEAL. SO PLEASE WAIT, WATCH & APPLY ANY IPO. AND PLEASE DON''T FOLLOW ANY GRAYMARKET PREMIUM. IT IS COMPANY STRATEGY

Application rate 400 rs hcg

This company has Azim Premji as a major investor.Apart from oncology ,they also run fertility clinics.Company has vast growth prospects.IPO valuation appears difficult as it has posted losses in the past.It is better to wait till it is listed for making any investment.

Is HGE subscriable ?
QH & PCL jevu thase ???

COMPANY HAS LOSS IN THE PAST. ABHI TO QUICKHEAL JAISA HI HAL HOGA AESA LAGTA HAI...

Avoid this high price issue.
Under these circumstances i will prefer not to apply looking at valuations 1850 Cr. which is still markets are though good still they should have left something for retail. I advice to wait and add such post listing. You will definitely get this at same valuation post listing. No point applying in IPO where risk is huge.
Already retailers lost huge money in QH & PCL

Eagleye
Please help in QH stuck. U also holding this.
Will you apply in healthcare ipo

welcome back
Eagleye
Happy to see you

Eagle eye whts ur opinion..
Is it subscribing or not?

super mario draghi has given more then what market wanted big bazooka for equity market all this money will flow in indian equity too

Yep...should be very positive for India equities...especially given that rate cut by RBI also becomes all the more real!

PRICES OF NEW IPO VERY HIGH ALL PREMIUM EATEN BY CO PROMOTERS NOTHING FOR RETAILERS.

On performance front, the company’s operations have been growing on top lines, but bottom lines were in negative. Its revenue and losses (on consolidated basis) for last five fiscals were Rs. 216.19 cr. /Rs. 6.30 cr. (FY 11), Rs. 270.22 cr. / (Rs. 3.33 cr.) (FY 12), Rs. 340.68 cr. / (Rs. 10.51 cr.) (FY 13), Rs. 455.06 cr. / (Rs. 35.55 cr.) (FY 14) and Rs. 524.19 cr./ Rs. 0.55 cr. (FY 15). For the eight months ended 30.11.15 of the current fiscal, it has posed loss of (Rs. 3.71 cr.) on a revenue of Rs. 381.28 cr. Thus on the basis of losses, its asking price it at a negative P/E. In the fiscal FY 15 and FY 16 it has incurred losses of about 9.30 crore on account of closing of unrewarding hospitals.

5% retail discount he ?

HCG GMP 22-23

eagleye whatever gmp on quickheal totally false its still at discount

Mehul Sir,

I dont the grey market prices ... I only give the rates as being quoted by the brokers.

Healthcare Global Enterprises Limited:
(On page 445 of RHP)

Anchor Investor Bids – March 15, 2016
Public Offer Opens – March 16, 2016
Public Offer Closes – March 18, 2016

Finalisation of Basis of Allotment – March 23, 2016
Unblocking of ASBA Accounts – March 28, 2016

Credit of Shares to Demat Accounts – March 29, 2016
Commencement of Trading – March 30, 2016

Thanx

guys market go down and will go down then whether to apply to ipo or not ?

Russia mulling air strikes in n.Korea : Russia foreign minister......n.korea will start nuclear war in asia region: kim.....time to remain cautious in market.....,(note:some 1 may irks)

Haan bhai terey USA going to strike NK ka kya hua? Ab Russia ke peechey pada hai. Reading some sh.t article from a shody magazine is ok but chavanni ke dimmag par bhi thoda Zor daal liya kar? Do u even understand geopolitical situations that u keep posting useless garbage here? Nothing is going to happen least of all Russia which is already involved in Syria. If anything has to happen it has to happen with concurrence of China. So keep ur calm n ur garbage to urself.

Healthcare Global Enterprises IPO attractive on strong growth potential...Economic Times

http://economictimes.indiatimes.com/markets/ipos/fpos/healthcare-global-enterprises-ipo-attractive-on-strong-growth-potential/articleshow/51336146.cms

http://economictimes.indiatimes.com/markets/ipos/fpos/healthcare-global-enterprises-ipo-attractive-on-strong-growth-potential/articleshow/51336146.cms

HGE PLZ KOSTAK

NEOTRADE i do not have issue with business model ... I have no issue with hub and spoke model also it give a multiplier effect....... My issue is how to value this with conventional hospital model which has asbacking not just medical equipment assets..... Yes HCG investment in medical equipment which we can see from the balance sheet which is financed via debt....

However u cannot put other brands apollo etc with HCG..... HCG is piggybacking on other small hospital infra which is tie-up with individual JV in different term and condition which could go sour and effect it growth...

Also given the structure room for mis management from third party cannot be ruled out...

I have no idea how FII and institutional will like HUB AND SPOKE MODEL .

my concern is u cannot value HCG same as other listed hospital business i think we should give at least 50% discount. Price to market cap was 4.5 for HCG after 50% Price to market cap 6.75 compare with Apollo is 4.29 times
Fortis is 13 times
NH is 7 times
so IMO premium could not more then 5% for a list price around Rs 230 given a low return better to avoid and wait for it list and actual play.

However if market think the discount is lower then 50% say 45% 40% 35% list range would approx 5% more for every 5% discount

so at 45% list could be rs 240 and so on....

let see how QIB and HNI take this stock

before making decision

I agree...hub and spoke model can throw challenges especially with bad performance of partner or JV...but I think given that they are 20 odd years old now...they would have improvised the model...and their current financials and EBITDA margins seem to suggest that the business with the partners is also stable...but yes, it is certainly something to watch out for!